Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Milazzo

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 13, 2012
Antibody response to common viruses and human leukocyte antigen-DRB1 in pediatric multiple sclerosisEmmanuelle Waubant, Ellen M Mowry, Lauren Krupp, et al.
Oncotarget|November 18, 2015
Intra-tumor AvidinOX allows efficacy of low dose systemic biotinylated Cetuximab in a model of head and neck cancerLoredana Vesci, Ferdinando Maria Milazzo, Anna Maria Anastasi, et al.
Frontiers in Oncology|February 11, 2020
ErbB2 Targeted Epigenetic Modulation: Anti-tumor Efficacy of the ADC Trastuzumab-HDACi ST8176AA1Ferdinando Maria Milazzo, Loredana Vesci, Anna Maria Anastasi, et al.
Chemical Communications (Cambridge, England)|January 12, 2021
Antibody drug conjugates with hydroxamic acid cargos for histone deacetylase (HDAC) inhibitionClaudio Cianferotti, Valentina Faltoni, Elena Cini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 22, 2010
Metabolic approach to the enhancement of antitumor effect of chemotherapy: a key role of acetyl-L-carnitineClaudio Pisano, Loredana Vesci, Ferdinando Maria Milazzo, et al.
Oncotarget|September 20, 2014
Efficacy of aerosol therapy of lung cancer correlates with EGFR paralysis induced by AvidinOX-anchored biotinylated CetuximabRita De Santis, Antonio Rosi, Anna Maria Anastasi, et al.
European Journal of Medicinal Chemistry|April 28, 2012
Isoxazolo(aza)naphthoquinones: a new class of cytotoxic Hsp90 inhibitorsAlberto Bargiotti, Loana Musso, Sabrina Dallavalle, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 15, 2022
Human inhalable antibody fragments neutralizing SARS-CoV-2 variants for COVID-19 therapyOlga Minenkova, Daniela Santapaola, Ferdinando Maria Milazzo, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 13, 2012
Antibody response to common viruses and human leukocyte antigen-DRB1 in pediatric multiple sclerosisEmmanuelle Waubant, Ellen M Mowry, Lauren Krupp, et al.
Oncotarget|November 18, 2015
Intra-tumor AvidinOX allows efficacy of low dose systemic biotinylated Cetuximab in a model of head and neck cancerLoredana Vesci, Ferdinando Maria Milazzo, Anna Maria Anastasi, et al.
Frontiers in Oncology|February 11, 2020
ErbB2 Targeted Epigenetic Modulation: Anti-tumor Efficacy of the ADC Trastuzumab-HDACi ST8176AA1Ferdinando Maria Milazzo, Loredana Vesci, Anna Maria Anastasi, et al.
Chemical Communications (Cambridge, England)|January 12, 2021
Antibody drug conjugates with hydroxamic acid cargos for histone deacetylase (HDAC) inhibitionClaudio Cianferotti, Valentina Faltoni, Elena Cini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 22, 2010
Metabolic approach to the enhancement of antitumor effect of chemotherapy: a key role of acetyl-L-carnitineClaudio Pisano, Loredana Vesci, Ferdinando Maria Milazzo, et al.
Oncotarget|September 20, 2014
Efficacy of aerosol therapy of lung cancer correlates with EGFR paralysis induced by AvidinOX-anchored biotinylated CetuximabRita De Santis, Antonio Rosi, Anna Maria Anastasi, et al.
European Journal of Medicinal Chemistry|April 28, 2012
Isoxazolo(aza)naphthoquinones: a new class of cytotoxic Hsp90 inhibitorsAlberto Bargiotti, Loana Musso, Sabrina Dallavalle, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 15, 2022
Human inhalable antibody fragments neutralizing SARS-CoV-2 variants for COVID-19 therapyOlga Minenkova, Daniela Santapaola, Ferdinando Maria Milazzo, et al.
Pageof 4